-
Recap of EMUC21: The take-home messages
November 30, 2021Being an event with a multidisciplinary nature, the take-home messages of the 13th European Multidisciplinary Congress on Urological Cancers...
0 -
Another EMUC21 day, another round of best poster award winners
November 28, 2021After three experts from three different fields had won the Best Poster Award – Prostate Cancer on the third...
-
Personalised approaches to treating GU cancers
November 27, 2021Personalised approaches such as the use of circulating tumour DNA (ctDNA) biomarkers and genetic testing is the way to...
-
EMUC21 shines spotlight on best poster winners
November 27, 2021Demonstrating the multidisciplinary nature of the congress, an oncologist, a radiotherapist, and a urologist each received a Best Poster...
-
Bladder-preserving strategies unveiled: Topical therapy and TURBT
November 26, 2021In order to preserve the quality of life for non-muscle-invasive bladder cancer (NMIBC) patients as much as possible, bladder-preserving...
-
PSMA PET/CT: Prime tool in staging and treatment monitoring
November 26, 2021Plenary Session 1 “Prostate cancer staging in 2021: Where are we, where are we going?” provided delegates with expert...
-
Strengths and limitations of PSMA PET: When to use it (and when not to)
November 26, 2021The prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is the (relatively) new kid on the block in...
-
Definitive: EMUC21 is coming to Athens!
September 24, 2021New crucial updates in GU cancer prevention, diagnosis and management Relive and enjoy the congress experience, meet and connect...
-
Radioligand therapy: multidisciplinary collaboration for health system readiness
September 13, 2021By the European Society for Medical Oncology (ESMO) team Join the EMUC21 session ‘Radioligand therapy: multidisciplinary collaboration for health...
